Literature DB >> 12615210

Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?

Peter Vanlandschoot1, Geert Leroux-Roels.   

Abstract

The co-existence of viruses and organisms for millions of years has influenced the evolution of both. Various viral strategies to enter a host and take over the control of cells to produce virus progeny have developed. Several antiviral (immune) responses have also been developed. The apoptotic death program is a conserved feature of eukaryotic cells. In multicellular organisms the binding and engulfment of apoptotic material is considered to be the end stage of the apoptotic process. Because of its importance, it seems probable that viruses have targeted this ancient removal system to suppress immune responses and to establish or maintain infection. The possibility that the hepatitis B virus has evolved such a mechanism, termed "viral apoptotic-like mimicry", is presented here.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615210     DOI: 10.1016/s1471-4906(03)00026-7

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  23 in total

Review 1.  Old and new adjuvants for hepatitis B vaccines.

Authors:  Geert Leroux-Roels
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

Review 2.  Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.

Authors:  Douglas R Rice; Kasey J Clear; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2016-07-07       Impact factor: 6.222

Review 3.  Exploiting death: apoptotic immunity in microbial pathogenesis.

Authors:  D S Ucker
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

4.  Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy.

Authors:  Xiaolei Zhuang; Norman R Watts; Ira W Palmer; Joshua D Kaufman; Altaira D Dearborn; Joni L Trenbeath; Elif Eren; Alasdair C Steven; Christoph Rader; Paul T Wingfield
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

5.  HBsAg Quantification in Clinical Practice.

Authors:  Avnish K Seth
Journal:  J Clin Exp Hepatol       Date:  2012-04-12

Review 6.  Hepatitis B virus large surface protein: function and fame.

Authors:  Yuri Churin; Martin Roderfeld; Elke Roeb
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

Review 7.  Apoptosis and apoptotic mimicry: the Leishmania connection.

Authors:  João Luiz M Wanderley; Marcello A Barcinski
Journal:  Cell Mol Life Sci       Date:  2010-02-07       Impact factor: 9.207

8.  Disruption of Phosphatidylserine Synthesis or Trafficking Reduces Infectivity of Ebola Virus.

Authors:  Patrick Younan; Mathieu Iampietro; Rodrigo I Santos; Palaniappan Ramanathan; Vsevolod L Popov; Alexander Bukreyev
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

9.  Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine.

Authors:  Paul E Makidon; Anna U Bielinska; Shraddha S Nigavekar; Katarzyna W Janczak; Jessica Knowlton; Alison J Scott; Nicholas Mank; Zhengyi Cao; Sivaprakash Rathinavelu; Michael R Beer; J Erby Wilkinson; Luz P Blanco; Jeffrey J Landers; James R Baker
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

Review 10.  Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of Poxviruses.

Authors:  Susanna R Bidgood; Jason Mercer
Journal:  Viruses       Date:  2015-08-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.